top of page

All Donations Matched 1X Until Dec 31, 2025

TAKE ACTION

Home
About Us
Education
Support for Patients & Caregivers
Resource Guide
Clinical Trials Guide
More

Use tab to navigate through the menu items.

Pheochromocytoma/ Paraganglioma

Pheochromocytoma/ Paraganglioma

Alpha PRRT with Pb-212 VMT
Alpha PRRT with RYZ401 in PRRT-naive Solid Tumors Expressing SSTRs
Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas
Belzutifan/MK-6482 in PNET + PPGL + VHL
BRAVESST2: CRN09682 in SST2-Expressing NENs and Other Solid Tumors
IL13Rα2 CAR T Cell Study for Solid Tumor Cancers
Olaparib + Usual Chemotherapy (Temozolomide) in PPGL
NETTER-P: Lutathera in Adolescent Patients
LAMPARA: LAnreotide in Metastatic Pheochromocytoma/PARAganglioma
Tarlatamab in DLL3-Expressing Tumors Including Neuroendocrine Neoplasms

NEUROENDOCRINE CANCER FOUNDATION

Mailing Address:

PO BOX 370466

DENVER, CO 80237

info@ncf.net

TERMS & CONDITIONS

© 2025 by Neuroendocrine Cancer Foundation

bottom of page